PATHELEN® Chronical Wound Treatment -  A new therapy to treat wound infections also with MRSA, MDR, ESBL, and other antibiotic-resistant-bacteria (Superbugs)

PAWT is a unique therapy which cures the most common chronic wound diseases such as diabetic foot ulcer (DFS), pressure ulcer (Dekubitus), and venous ulcers (ulcus cruris). 

 

Through its revolutionary strategy, a local physical adsorption treatment of wound bacteria is used instead of the traditional approach of a systemic antibiotic treatment. PAWT can even successfully  treat  "hard-to heal" wound infections,  which are "protected" by a Biofilm or wounds which are contaminated with antibiotic resistant MRSA and Extended spectrum beta lactamases (ESBL) producing bacteria like Escherichia coli (EHEC; E.coli) and Klebsiella. 

 

The first ambulant PAWT facility is planned to open in Switzerland in 2016

 

The unique effect of PATHELEN® THERAPY is achieved through various simultaneous complex mechanisms of:

 

• Elimination of the biofilm

• Sorption of necrotic tissues

• Sorption of pus and toxins (including large amounts of problematic lipopolysaccharides)

• Preparation of a physiological wound environment with granulating tissue

 

It can be observed that the general  condition of a patient  improves significantly after the first application of Pathelen® along with a decrease in wound pain. Additionally, the application of the first PATHELEN® Treatment reduces the risk of a sepsis significantly. 

 

The combination of components, the manufacturing process, and the areas of application have been filed for patent in November 2013.


CASE STUDIES USING PATHELEN® ANTIBACTERIAL WOUND TREATMENT (PAWT)

Starting in 2014, the PATHELEN® ANTIBACTERIAL WOUND TREATMENT has been successfully applied to various patients and in different hospitals.

Below are some examples of successful treatments of MRSA infected wounds:

Patient: M.M., 78 y.o. , female

Diagnosis: Necrotizing fasciitis of the left shin. Thrombophlebitis of the left tibia. Chronic venous insufficiency 6c.  The wound was infected with MDR.

Start Pathelen® treatment (PAWT)

PAWT

9 days after PAWT full coverage of the wound by granulation. Start of epithelization



Patient: M.S., 65 y.o. , male
Diagnosis: Venous trophic ulcer VI stage according to international classifier of chronical vein diseases СЕАР. Sickness duration 8 months. The wound was infected with MRSA.

Start Pathelen® treatment (PAWT)

After 5 days - wound is actively granulated and epithelialized. PAWT was terminated.

Status after skin net surgery.

55 days after skin net surgery



Patient: T.V., 48 y.o. , male

Diagnosis: Type 2 diabetes mellitus, diabetic foot syndrome neuropathic form, and trophic ulcer, Wagner 3. The wound was infected with MRSA.

Start Pathelen® treatment (PAWT)

PAWT

After 11 days - wound is actively granulated
and epithelialized. PAWT was terminated